Viewing StudyNCT00217425



Ignite Creation Date: 2024-05-05 @ 12:02 PM
Last Modification Date: 2024-10-26 @ 9:19 AM
Study NCT ID: NCT00217425
Status: COMPLETED
Last Update Posted: 2023-06-18
First Post: 2005-09-20

Brief Title: Bevacizumab and Combination Chemotherapy in Treating Patients With Peripheral T-Cell Lymphoma or Natural Killer Cell Neoplasms
Sponsor: Eastern Cooperative Oncology Group
Organization: Eastern Cooperative Oncology Group

Conditions & Keywords Data

Conditions:
Name
Lymphoma
Keywords:
Name View
peripheral T-cell lymphoma View
anaplastic large cell lymphoma View
stage I adult T-cell leukemialymphoma View
stage II adult T-cell leukemialymphoma View
stage III adult T-cell leukemialymphoma View
stage IV adult T-cell leukemialymphoma View